Lee Yuchun's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 8, 2022
- Accession no.
- 0000899243-22-014367
- Filed
- Apr 8, 2022
- Trade date
- Apr 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.09M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee YuchunCIK 0001334365 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 | Common Stock | MOption exerciseAcquired | +2,000 | $81.54 | +$163,080 | 3,875 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −17 | $267.57 | −$4,548.69 | 3,858 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −300 | $270.67F2,F3 | −$81,201 | 3,558 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −1,600 | $271.78F2,F4 | −$434,848 | 1,958 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −83 | $272.84F2,F5 | −$22,645.72 | 1,875 | Direct | |
| Apr 7, 2022 | Common Stock | MOption exerciseAcquired | +2,000 | $81.54 | +$163,080 | 3,875 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −417 | $272.76F2,F7 | −$113,740.92 | 3,458 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −500 | $273.78F2,F8 | −$136,890 | 2,958 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −256 | $275.26F2,F9 | −$70,466.56 | 2,702 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −727 | $276.37F2,F10 | −$200,920.99 | 1,975 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −100 | $277.02 | −$27,702 | 1,875 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 14,000 | Direct | |
| Apr 7, 2022 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 12,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 7 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $270.67 (range $270.42 to $270.88).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $271.78 (range $271.43 to $272.33).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $272.84 (range $272.56 to $272.97).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $272.76 (range $272.50 to $273.28).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $273.78 (range $273.52 to $273.98).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $275.26 (range $274.64 to $275.43).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $276.37 (range $275.94 to $276.82).
Referenced by the price of 1 transaction in Table I.